UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Mucosal Immunology/HIV


The Department of Medicine

Division of Digestive Diseases / Gastroenterology

Mucosal Immunology/HIV

Identifying and characterizing how the body's immune system in the GI tract (which holds 60-70% of the total body's immune cells) recognizes and fights HIV is a vital step in understanding how to prevent (vaccines and microbicides), treat, and potentially cure HIV infection. The gastrointestinal tract is the major site for first infection by HIV (regardless of how the virus first enters the body), active viral replication and spread as well as being the main reservoir of the virus.

Dr. Peter Anton, Professor of Medicine at the David Geffen School of Medicine at UCLA, is Director of the UCLA Center for HIV Prevention Research (CPR), Core Director of the UCLA Center for AIDS Research (CFAR) Mucosal Immunology Core Laboratory (MICL), and Co-Director of the UCLA IBD Center. He has been with the Division of Digestive Diseases for more than 24 years, and his group was among the first to demonstrate that HIV infection triggers a persistent, active form of inflammatory bowel disease which can be viewed as a chronic infectious counterpart to the more conventional inflammatory bowel diseases (ulcerative colitis/Crohns disease).

For more information, please visit the Division of Digestive Diseases website: http://gastro.ucla.edu

Director Specialty
Anton, Peter MD Digestive Diseases